Arsenal

First Timers Club: Biopharma Launches in 2025 and 2026

Arsenal March 13, 2025

Insilico Medicine raises $110M for new trials and robots

Arsenal March 13, 2025

Biotechs Trading Below Enterprise Value: Zombies, Comebacks, and Caution Ahead

Arsenal March 10, 2025

The Art and Science of Drug Naming – PALFYDEV

Arsenal March 7, 2025

HCP Marketing Personalization in Pharma: Proven Strategies & ROI Insights

Arsenal March 6, 2025

Milestone Pharma: Overview and Outlook

Arsenal March 3, 2025

Crinetics Pharma Tear Sheet

Arsenal February 20, 2025

From Clinical Trials to Market Triumph: The Ultimate Playbook for First-Time US Drug Launches

Arsenal February 11, 2025

Bristol Myers Squibb Unveils $2 Billion Strategic Productivity Initiative

Arsenal February 10, 2025

Emerging Innovations in Acromegaly Treatments: Revolutionizing the Landscape

Arsenal February 7, 2025

Circular RNA: The Next Biopharma Revolution Beyond mRNA

Arsenal July 31, 2024

GSK, Flagship Invest $150M in Respiratory and Immunology Programs

Arsenal July 30, 2024

Amylyx Rebounds with GLP-1 Drug Acquisition and Promising Pipeline

Arsenal July 24, 2024

Biotech Layoffs: Navigating Legal Risks During Restructuring

Arsenal July 17, 2024

Eli Lilly’s Tirzepatide: A Potential Game-Changer in Weight-Loss Drugs

Arsenal July 16, 2024

Congress: Renew FDA Pediatric Rare Disease Program

Arsenal July 15, 2024

Reauthorize FDA’s Priority Review Voucher Program for Pediatric Rare Diseases

Arsenal July 15, 2024

FDA Rejects Novo’s Once-Weekly Insulin Icodec: 2024 Decision Tracker

Arsenal July 12, 2024

Top 10 Tips to Harness AI’s Power in Biotech Drug Development

Arsenal July 10, 2024

Mesoblast Resubmits BLA to FDA for Ryoncil in Pediatric SR-aGVHD Treatment

Arsenal July 9, 2024

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

WuXi AppTec Faces US Revenue Decline for First Time in Five Years: Impacts of the Biosecure Act

UK Government’s Controversial Move: Doubling Pharmaceutical Rebates Could Impact NHS Funding and Drug Prices

First Timers Club: Biopharma Launches in 2025 and 2026

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA

Arsenal

First Timers Club: Biopharma Launches in 2025 and 2026

Insilico Medicine raises $110M for new trials and robots

Biotechs Trading Below Enterprise Value: Zombies, Comebacks, and Caution Ahead

The Art and Science of Drug Naming – PALFYDEV

HCP Marketing Personalization in Pharma: Proven Strategies & ROI Insights

Milestone Pharma: Overview and Outlook

Crinetics Pharma Tear Sheet

From Clinical Trials to Market Triumph: The Ultimate Playbook for First-Time US Drug Launches

Bristol Myers Squibb Unveils $2 Billion Strategic Productivity Initiative

Emerging Innovations in Acromegaly Treatments: Revolutionizing the Landscape

Circular RNA: The Next Biopharma Revolution Beyond mRNA

GSK, Flagship Invest $150M in Respiratory and Immunology Programs

Amylyx Rebounds with GLP-1 Drug Acquisition and Promising Pipeline

Biotech Layoffs: Navigating Legal Risks During Restructuring

Eli Lilly’s Tirzepatide: A Potential Game-Changer in Weight-Loss Drugs

Congress: Renew FDA Pediatric Rare Disease Program

Reauthorize FDA’s Priority Review Voucher Program for Pediatric Rare Diseases

FDA Rejects Novo’s Once-Weekly Insulin Icodec: 2024 Decision Tracker

Top 10 Tips to Harness AI’s Power in Biotech Drug Development

Mesoblast Resubmits BLA to FDA for Ryoncil in Pediatric SR-aGVHD Treatment

Stay up to date on the latest news

Access the Ideas that Accelerate Innovation

Trending News

WuXi AppTec Faces US Revenue Decline for First Time in Five Years: Impacts of the Biosecure Act

UK Government’s Controversial Move: Doubling Pharmaceutical Rebates Could Impact NHS Funding and Drug Prices

First Timers Club: Biopharma Launches in 2025 and 2026

Popular Categories

Information

Contact Us